ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CME Symposium- Case Challenges with #Antiplatelet Therapy

By: PRLog

This CME Symposium takes place during the 2022 AHA Annual Scientific Sessions on Friday, November 4, 2022 from 6:30 PM - 8:00 PM CT at the Marriott Marquis Chicago, 2121 South Prairie, Avenue, Chicago, IL.

BOONTON, N.J. - Sept. 23, 2022 - PRLog -- In this CME Symposium, during the 2022 American Heart Association (#AHA) Annual Scientific sessions, expert faculty will describe best practices for assessing #ischemic risk and bleeding risk after PCI, and in 3 challenging cases, supported by current clinical trial evidence, identify patients for bleeding risk-reduction strategies with #antiplatelet therapy, and patients for consideration of prolonged dual therapy.

For more information

CHAIR:

Deepak L. Bhatt, MD, MPH
Executive Director of Interventional
Cardiovascular Programs
Brigham and Women's Hospital Heart & Vascular Center
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

FACULTY:

Marc P. Bonaca, MD, MPH
Executive Director, CPC Clinical Research
Director of Vascular Research
Associate Professor of Medicine
William R. Hiatt Endowed Chair in Cardiovascular Research
University of Colorado School of Medicine
Aurora, Colorado

Roxana Mehran, MD
Professor of Medicine
Director of Interventional Cardiovascular Research and Clinical Trials
Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
New York, New York

Philippe Gabriel Steg, MD
Professor of Cardiology
Université Paris–Diderot
Département de Cardiologie
Hôpital Bichat
Paris, France

Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

This educational activity is intended for #cardiologists and other clinicians managing patients with #cardiovasculardisease.

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Pre-registration is for planning purposes only. For additional CME activities and online cme courses visit CMEPlanet. #AHA #cardiology #heartdisease #hearthealth #cardiologist #cardiovascular #antiplatelettherapy #ACS

Contact
Voxmedia LLC
***@voxmedia.us

Photos: (Click photo to enlarge)

Voxmedia Logo 2022 AHA Symposium Antiplatelet

Read Full Story - CME Symposium- Case Challenges with #Antiplatelet Therapy | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.